Literature DB >> 7498281

Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.

S Khan1, N Brooks, R Whelpton, A T Michael-Titus.   

Abstract

The effects of substance P, substance P-(1-7) and substance P-(5-11) on endogenous dopamine outflow in rat striatal slices were investigated. The dose-response curves (0.01 nM to 10 microM) were bell-shaped, with significant increases at 0.1 and 1 nM but with no effect at higher concentrations. The tachykinin NK1 receptor agonist, [Sar9,Met(O2)11]substance P, significantly increased dopamine outflow at 10 and 100 nM. The effects of substance P or substance P-(5-11) and 25 mM KCl were additive. A negative interaction was observed with substance P-(1-7) and K+. The increase in dopamine outflow elicited by 1 nM substance P and substance P-(5-11) was reversed by the tachykinin NK1 receptor antagonist WIN 51,708 (17 beta-hydroxy-17 alpha-ethynyl-5 alpha-androstano[3,2-b]pyrimido[1,2- alpha]benzimidazole) (25 and 250 nM), whereas only partial reversal was observed for the effect of substance P-(1-7). These results show that substance P fragments locally modulate striatal dopamine outflow and the mechanisms underlying this modulation may differ between N- and C-terminal fragments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498281     DOI: 10.1016/0014-2999(95)00342-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.

Authors:  S V Nikolaev; A A Lebedev; E R Bychkov; A V Oblyapin; S A Dambinova; P D Shabanov
Journal:  Neurosci Behav Physiol       Date:  2004-09

2.  The insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) in Parkinson's disease.

Authors:  Spiridon Papapetropoulos; Kostantinos Glynos; Zongmin Zhou; Stylianos E Orfanos; Georgia Mitsi; Andreas Papapetropoulos
Journal:  Open Neurol J       Date:  2008-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.